Reducing Infection Risk Without Compromising Performance
Endoscopic retrograde cholangiopancreatography (ERCP) carries the potential for serious infectious complications that can be multidrug-resistant and life threatening.1,2,3 Up to 1% of duodenoscope-related infections are associated with carbapenem-resistant Enterobacteriaceae (CRE),4 with mortality rates in multidrugresistant cases shown to reach as high as 70%.5
Single‑use duodenoscope technology has emerged as an important advancement in infection prevention, offering a sterile, ready‑to‑use alternative to reusable scopes that require complex reprocessing. At Boston Scientific, we have been advancing single-use duodenoscope technology since launching the world's first single-use duodenoscope in 2019.
Purpose‑Built Innovation for Infection Mitigation and Efficient ERCP
As the only single-use duodenoscope with seven peer-reviewed studies evaluating feasibility, safety, and performance, our fourth-generation EXALT™ Model D Single-Use Duodenoscope demonstrates our commitment to continuous innovation. Its evolution is driven by physician feedback, delivering the consistent flexibility, manoeuvrability, and out-ofthe- box performance physicians expect from a duodenoscope.
Learn more about the disposable EXALT™ Model D Single-Use Duodenoscope
Benefits of the EXALT™ Model D Single-Use Duodenoscope during ERCP
Next-generation single-use duodenoscopes are designed to provide more consistent support during ERCP by addressing the day-to-day challenges associated with reusable platforms. The ergonomic fourth-generation EXALT™ Model D offers:
